![Patrick J. Fortune](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick J. Fortune
Direktor/Vorstandsmitglied bei
Epigenesis Pharmaceuticals LLC
Profil
Patrick J.
Fortune is currently a Director at CardioMEMS LLC, Sapphire Therapeutics, Inc., the University of Illinois, and Epigenesis Pharmaceuticals LLC.
He previously held positions as Executive Chairman at Knowledge Impact, Inc., Independent Director at PAREXEL International Corp., President, Chief Operating Officer & Director at New Era of Networks, Inc., and President-Parenteral Products Division at Baxter International, Inc. He also served as a Director at EPIX Pharmaceuticals, Inc., CombinatoRx, Inc., Collegium Pharmaceutical, Inc., Histogenics Corp., PreCision Dermatology, Inc., GlycoFi, Inc., and Helio Vision, Inc. Additionally, he was a Vice President-Information Management at Bristol Myers Squibb Co., Senior Vice President & General Manager at Packaging Corporation of America, and Chief Information Officer at Monsanto Co. He was also a Partner at Boston Millennia Partners III LP and an Operating partner at Boston Millennia Partners.
He has advised The University of Chicago.
He holds an MBA from Northwestern University and undergraduate and doctorate degrees from the University of Wisconsin.
Aktive Positionen von Patrick J. Fortune
| Unternehmen | Position | Beginn |
|---|---|---|
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines | Direktor/Vorstandsmitglied | - |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Direktor/Vorstandsmitglied | - |
CardioMEMS LLC
 CardioMEMS LLC Medical SpecialtiesHealth Technology Designs and manufactures wireless sensing and communication technology for the human body | Direktor/Vorstandsmitglied | 01.05.2005 |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Patrick J. Fortune
| Unternehmen | Position | Ende |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Direktor/Vorstandsmitglied | 29.09.2017 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Direktor/Vorstandsmitglied | 01.01.2009 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Direktor/Vorstandsmitglied | 01.01.2008 |
Knowledge Impact, Inc.
 Knowledge Impact, Inc. Packaged SoftwareTechnology Services Provides application software services | Vorsitzender | 01.06.2005 |
New Era of Networks, Inc.
 New Era of Networks, Inc. Information Technology ServicesTechnology Services Provides internet infrastructure software and services | Präsident | 01.06.2001 |
Ausbildung von Patrick J. Fortune
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
24
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
New Era of Networks, Inc.
New Era of Networks, Inc. Information Technology ServicesTechnology Services Provides internet infrastructure software and services | Technology Services |
Packaging Corporation of America
 Packaging Corporation of America Containers/PackagingProcess Industries Manufactures containerboard and corrugated packaging products | Process Industries |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
CardioMEMS LLC
CardioMEMS LLC Medical SpecialtiesHealth Technology Designs and manufactures wireless sensing and communication technology for the human body | Health Technology |
Sapphire Therapeutics, Inc.
Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Boston Millennia Partners III LP
 Boston Millennia Partners III LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Finance |
Knowledge Impact, Inc.
Knowledge Impact, Inc. Packaged SoftwareTechnology Services Provides application software services | Technology Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Epigenesis Pharmaceuticals LLC
Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines | Health Technology |
Coram Healthcare Corp.
 Coram Healthcare Corp. Hospital/Nursing ManagementHealth Services Provides home nursing services | Health Services |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Develop a therapy for fibro proliferative disorders that lead to abnormal scarring and blindness after retina surgery | Health Technology |
Wählen Sie MarketScreener 
